DSM completes Martek acquisition

by Jeff Gelski
Share This:

HEERLEN, THE NETHERLANDS — Royal DSM N.V. has completed its acquisition of Martek Biosciences Corp. Columbia, Md., for €790 million ($1,087 million), DSM said Feb. 28. The acquisition, first announced on Dec. 21, 2010, adds a new growth platform for healthy and natural food ingredients for infant formula and other food and beverage applications, especially those focused on polyunsaturated fatty acids such as microbial omega-3 fatty acid DHA (docosahexaenoic acid) and omega-6 fatty acid ARA (arachidonic acid).

An integration team consisting of both DSM and Martek representatives will assess the best way to combine the two organizations.

Comment on this Article
We welcome your thoughtful comments. Please comply with our Community rules.



The views expressed in the comments section of Food Business News do not reflect those of Food Business News or its parent company, Sosland Publishing Co., Kansas City, Mo. Concern regarding a specific comment may be registered with the Editor by clicking the Report Abuse link.